Furiex Pharmaceuticals, Inc. 4/A
4/A · Furiex Pharmaceuticals, Inc. · Filed Sep 18, 2013
Insider Transaction Report
Form 4/AAmended
CORR PETER B
Director
Transactions
- Exercise/Conversion
Common Stock
2013-06-24$9.11/sh+3,600$32,796→ 7,180 total - Exercise/Conversion
Common Stock
2013-06-25$9.11/sh+1,000$9,110→ 8,180 total